MX2015005111A - Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada. - Google Patents

Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.

Info

Publication number
MX2015005111A
MX2015005111A MX2015005111A MX2015005111A MX2015005111A MX 2015005111 A MX2015005111 A MX 2015005111A MX 2015005111 A MX2015005111 A MX 2015005111A MX 2015005111 A MX2015005111 A MX 2015005111A MX 2015005111 A MX2015005111 A MX 2015005111A
Authority
MX
Mexico
Prior art keywords
herbal composition
tnf
prevention
treatment
mediated diseases
Prior art date
Application number
MX2015005111A
Other languages
English (en)
Inventor
Somesh Sharma
Geetanjali Chandrashekhar Chimote
Becky M Thomas
Jacqueline Vinodkumar Trivedi
Jayasree Sreenivasan
Mahesh G Jadhav
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of MX2015005111A publication Critical patent/MX2015005111A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

El presente invento se relaciona con una composición para el uso en la prevención o tratamiento de una enfermedad mediada por TNF- a. El presente invento también provee un método para la preparación de la composición a base de hierbas y métodos para utilizar tal composición.
MX2015005111A 2012-10-23 2013-10-22 Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada. MX2015005111A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261717131P 2012-10-23 2012-10-23
PCT/IB2013/059538 WO2014064609A2 (en) 2012-10-23 2013-10-22 HERBAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF TNF-α MEDIATED DISEASES

Publications (1)

Publication Number Publication Date
MX2015005111A true MX2015005111A (es) 2015-09-23

Family

ID=49998601

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005111A MX2015005111A (es) 2012-10-23 2013-10-22 Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.

Country Status (14)

Country Link
US (1) US20150265651A1 (es)
EP (1) EP2911679A2 (es)
JP (1) JP2015535236A (es)
KR (1) KR20150084019A (es)
CN (1) CN104853761A (es)
AR (1) AR093103A1 (es)
AU (1) AU2013336251A1 (es)
BR (1) BR112015009179A2 (es)
CA (1) CA2889136A1 (es)
IL (1) IL238411A0 (es)
MX (1) MX2015005111A (es)
RU (1) RU2015119338A (es)
TW (1) TW201427677A (es)
WO (1) WO2014064609A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016020724A1 (en) * 2014-08-07 2016-02-11 Piramal Enterprises Limited Sphaeranthus indicus composition as il-17 inhibitor and uses thereof
CN104383119A (zh) * 2014-10-23 2015-03-04 广西金臣科技有限公司 菊花植物发酵液及其制备方法
US20190000079A1 (en) * 2015-01-20 2019-01-03 Lipotec Laboratories, Llc Methods and Formulation for Treatment of Nuts, Seeds, Grains, Cereals, Plant Growth Media, and Plants
KR102197858B1 (ko) 2019-08-20 2021-01-05 이기훈 혼합 생약 추출물을 유효성분으로 포함하는 건선 예방 또는 치료용 약학적 조성물
KR20240048167A (ko) 2022-10-06 2024-04-15 건국대학교 글로컬산학협력단 울금을 이용한 낙산균 발효물을 포함하는 염증성 장질환 개선용 건강기능식품

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA95908B (en) * 1995-02-06 1995-10-13 Joshi Yeshwant Dr Kashinath A synergistic formulation for treatment of rheumatic diseases
EP1931366B1 (en) * 2005-09-30 2013-05-29 Piramal Enterprises Limited Herbal composition for inflammatory disorders
PT1931366E (pt) * 2005-09-30 2013-09-04 Piramal Entpr Ltd Composição herbal para desordens inflamatórias
CA2751227C (en) * 2009-02-02 2021-10-26 Laila Nutraceuticals Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
US8071524B2 (en) * 2009-05-18 2011-12-06 Hoover, Inc. Biodegradable wipe utilizing bio-based lubricant comprising refined soybean oil
WO2011083397A1 (en) * 2010-01-05 2011-07-14 Himalaya Global Holdings Limited Herbal composition for skin disorders
AU2010345338B2 (en) * 2010-02-15 2014-03-13 Laila Nutraceuticals A novel Boswellia low polar gum resin extract and its synergistic compositions

Also Published As

Publication number Publication date
CN104853761A (zh) 2015-08-19
AU2013336251A1 (en) 2015-06-04
KR20150084019A (ko) 2015-07-21
EP2911679A2 (en) 2015-09-02
TW201427677A (zh) 2014-07-16
US20150265651A1 (en) 2015-09-24
RU2015119338A (ru) 2016-12-20
WO2014064609A2 (en) 2014-05-01
WO2014064609A3 (en) 2014-07-24
CA2889136A1 (en) 2014-05-01
IL238411A0 (en) 2015-06-30
BR112015009179A2 (pt) 2017-07-04
JP2015535236A (ja) 2015-12-10
AR093103A1 (es) 2015-05-20

Similar Documents

Publication Publication Date Title
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MX2013012053A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
IN2014MN00948A (es)
IN2014MN00987A (es)
HUE041553T2 (hu) Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
MX2014015004A (es) Inhibidores de bromodominio de benzo [c] isoxazoloazepina y sus usos.
IN2014MN02049A (es)
IN2014MN02069A (es)
MX2022004300A (es) Composicion y metodo para el diagnostico y tratamiento de enfermedades asociadas con la degeneracion de neuritas.
AP2014007804A0 (en) Compositions and methods for the treatment of hepatic diseases and disorders.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
WO2013022740A3 (en) Gpr35 ligands and the uses thereof
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
GB2497453B (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
GB201213484D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods of using the same
EP2709632A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX364704B (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
MX2016005645A (es) Composicion farmaceutica topica de acitretina.